Explore
Our Tests
Provider Services
Biopharma Partner Services
Latest CDx Indication
FoundationOne®Liquid CDx, the broadest FDA-approved liquid biopsy, is now the only blood-based comprehensive genomic profiling companion diagnostic (CDx) for Lynparza® (olaparib) in prostate cancer.
Provider FAQ
Provider Resources
Biopharma Partner FAQ
Biopharma Resources
Patient FAQs
Patient Resources
Useful Information
About Us